Our study aims to provide a greater depth of understanding the role of MAO-A in lung cancer, exploring the binding interactions of MAO-A with known inhibitors, building a pharmacophore model for MAO-A inhibitors, and designing MAO-A inhibitors using structure-based and ligand-based approaches. Here, MAOA is linked to lung carcinoma.